[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Human Microbiome Therapeutics Market Report 2017

January 2018 | 95 pages | ID: U552D887CF1EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Human Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Human Microbiome Therapeutics in these regions, from 2012 to 2022 (forecast).
United States Human Microbiome Therapeutics market competition by top manufacturers/players, with Human Microbiome Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • ENTEROME Bioscience
  • Rebiotix
  • Seres Therapeutics
  • Vedanta Biosciences
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Takeda Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Upper GIT
  • Lower GIT
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Intestines And Stomach
  • Oral
  • Respiratory Tract
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human Microbiome Therapeutics Market Report 2017

1 HUMAN MICROBIOME THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Human Microbiome Therapeutics
1.2 Classification of Human Microbiome Therapeutics by Product Category
  1.2.1 United States Human Microbiome Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Microbiome Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Upper GIT
  1.2.4 Lower GIT
1.3 United States Human Microbiome Therapeutics Market by Application/End Users
  1.3.1 United States Human Microbiome Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Intestines And Stomach
  1.3.3 Oral
  1.3.4 Respiratory Tract
  1.3.5 Other
1.4 United States Human Microbiome Therapeutics Market by Region
  1.4.1 United States Human Microbiome Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Microbiome Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Human Microbiome Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Microbiome Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Human Microbiome Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Human Microbiome Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Microbiome Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Microbiome Therapeutics (2012-2022)
  1.5.1 United States Human Microbiome Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Microbiome Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN MICROBIOME THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Microbiome Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Microbiome Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Microbiome Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Microbiome Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Human Microbiome Therapeutics Market Concentration Rate
  2.4.2 United States Human Microbiome Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Microbiome Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Microbiome Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Human Microbiome Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Human Microbiome Therapeutics Price by Region (2012-2017)

4 UNITED STATES HUMAN MICROBIOME THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Microbiome Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Human Microbiome Therapeutics Price by Type (2012-2017)
4.4 United States Human Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN MICROBIOME THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Microbiome Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Human Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN MICROBIOME THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 ENTEROME Bioscience
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ENTEROME Bioscience Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Rebiotix
  6.2.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Rebiotix Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Seres Therapeutics
  6.3.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Seres Therapeutics Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Vedanta Biosciences
  6.4.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Vedanta Biosciences Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Takeda Pharmaceutical
  6.7.2 Human Microbiome Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 HUMAN MICROBIOME THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Human Microbiome Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Microbiome Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Microbiome Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Microbiome Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN MICROBIOME THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Microbiome Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Microbiome Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Microbiome Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Microbiome Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Human Microbiome Therapeutics
Figure United States Human Microbiome Therapeutics Market Size (K Units) by Type (2012-2022)
Figure United States Human Microbiome Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Upper GIT Product Picture
Figure Lower GIT Product Picture
Figure United States Human Microbiome Therapeutics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Human Microbiome Therapeutics by Application in 2016
Figure Intestines And Stomach Examples
Table Key Downstream Customer in Intestines And Stomach
Figure Oral Examples
Table Key Downstream Customer in Oral
Figure Respiratory Tract Examples
Table Key Downstream Customer in Respiratory Tract
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Human Microbiome Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Microbiome Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Human Microbiome Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Human Microbiome Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Microbiome Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Human Microbiome Therapeutics Sales Share by Players/Suppliers
Figure United States Human Microbiome Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Microbiome Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Microbiome Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Microbiome Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Human Microbiome Therapeutics Revenue Share by Players/Suppliers
Table United States Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Human Microbiome Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Human Microbiome Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Microbiome Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Microbiome Therapeutics Product Category
Table United States Human Microbiome Therapeutics Sales (K Units) by Region (2012-2017)
Table United States Human Microbiome Therapeutics Sales Share by Region (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Share by Region (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Market Share by Region in 2016
Table United States Human Microbiome Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Microbiome Therapeutics Revenue Share by Region (2012-2017)
Figure United States Human Microbiome Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Human Microbiome Therapeutics Revenue Market Share by Region in 2016
Table United States Human Microbiome Therapeutics Price (USD/Unit) by Region (2012-2017)
Table United States Human Microbiome Therapeutics Sales (K Units) by Type (2012-2017)
Table United States Human Microbiome Therapeutics Sales Share by Type (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Share by Type (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Market Share by Type in 2016
Table United States Human Microbiome Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Microbiome Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Microbiome Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Human Microbiome Therapeutics by Type in 2016
Table United States Human Microbiome Therapeutics Price (USD/Unit) by Types (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Human Microbiome Therapeutics Sales (K Units) by Application (2012-2017)
Table United States Human Microbiome Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Market Share by Application in 2016
Table United States Human Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Human Microbiome Therapeutics Sales Growth Rate by Application (2012-2017)
Table ENTEROME Bioscience Basic Information List
Table ENTEROME Bioscience Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Rebiotix Basic Information List
Table Rebiotix Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Seres Therapeutics Basic Information List
Table Seres Therapeutics Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Vedanta Biosciences Basic Information List
Table Vedanta Biosciences Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Human Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Microbiome Therapeutics
Figure Manufacturing Process Analysis of Human Microbiome Therapeutics
Figure Human Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Human Microbiome Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Human Microbiome Therapeutics
Table Distributors/Traders List
Figure United States Human Microbiome Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Microbiome Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Type in 2022
Table United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Application in 2022
Table United States Human Microbiome Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Human Microbiome Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Microbiome Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories